Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

FED 1

Study Type

Interventional 12Observational 1Expanded_access 1

Sponsor

Cancer Type

Plasma cell 2Sarcoma 1Lymphoid 1

Conditions

Multiple Myeloma 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Blood Specimen Collection 14Surveys and Questionnaires 13Surgical Procedures, Operative 12Gene Expression Profiling 10Observation 7Amplified Fragment Length Polymorphism Analysis 7Polymerase Chain Reaction 6Drug Therapy 6Radiotherapy 5Microarray Analysis 5Immunohistochemistry 5Psychiatric Rehabilitation 4Imatinib Mesylate 4Base Sequence 4regorafenib 3Trabectedin 3Tissue Banks 3Therapeutics 3Sunitinib 3Specimen Handling 3Reverse Transcriptase Polymerase Chain Reaction 3Radiation 3Methods 3Magnetic Resonance Imaging 3Interviews as Topic 3Doxorubicin 3Biopsy 3ripretinib 2mifamurtide 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × selinexor × Sarcoma × Clear all
NCT06452446 2025-02-10

Selinexor

Durham VA Medical Center

Active not recruiting
20 enrolled
Plasma cellSarcoma

Multiple Myeloma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡